Raphael J. Leo, MA, MD

Department of Psychiatry, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York

  • 20Articles
  • 98.8KReads
  • 1996–2026Active
  • 22Collaborators
  • 2.9KCitations

About

Raphael J. Leo, MA, MD is affiliated with Department of Psychiatry, Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo, Buffalo, New York. Raphael J. Leo has authored or co-authored 20 peer-reviewed articles published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders between 1996 and 2026. Their work focuses on Addiction, Movement Disorders, Neurology, Psychiatry, and Schizophrenia/Schizoaffective Disorders.

Publications

PCC
Recreational Ketamine-Induced Uropathy
Brief Report

Recreational Ketamine-Induced Uropathy

March 19, 2026

Two patients with chronic recreational ketamine use presented with urinary frequency, urgency, dysuria, and hematuria in the absence of infection.
, , , et al
PCC
Clozapine-Related Cecal Volvulus
Case Report

Clozapine-Related Cecal Volvulus

July 11, 2024

This case of clozapine-related cecal volvulus illustrates the need for a high index of suspicion for potentially life-threatening surgical emergencies in clozapine-treated patients.
, , , et al
PCC
Recreational Use of 2M2B
Case Report

Recreational Use of 2M2B

November 22, 2022

This report describes a patient whose use of 2-methyl-2-butanol—an inexpensive, easily accessible, potent, and nondetectable ethanol substitute—led to protracted intoxication and delirium.
,
PCC
Mania Associated With Rhodiola Rosea
Case Report

Mania Associated With Rhodiola Rosea

March 17, 2022

In this report, the authors describe a patient whose use of Rhodiola rosea led to hospital presentation with mania.
,
PCC
Case Report

Phenibut: A Novel Nootropic With Abuse Potential

August 13, 2020

The anxiolytic phenibut has gained popularity due to its availability online, despite being banned by the FDA. This case report illustrates the misuse and abuse potential and life-threatening consequences.
,
PCC
Letter to the Editor

Oxcarbazepine-Induced Stevens-Johnson Syndrome

December 20, 2018

The incidence of oxcarbazepine-associated Stevens-Johnson syndrome is estimated to range between 0.5-6 cases/million per year. If you' re one of those cases, then there is a 100% chance you'...
, ,
PCC
Letter to the Editor

Tianeptine Sodium: A Nootropic With Potentially Lethal Consequences

July 19, 2018

Read a report on how the nootropic, Tianeptine sodium, led to unintended life-threatening consequences for a patient.
,
JCP
Case Report

Olfactory Tumor: Schizophrenia Misdiagnosis

January 27, 2016

Read a case of a patient with an olfactory groove meningioma (brain tumor) who was misdiagnosed with schizophrenia.
,
PCC
Letter to the Editor

A Case of Lithium-Induced Symptomatic Hypercalcemia

July 22, 2010

, ,
PCC
Letter to the Editor

Carbidopa-Levodopa-Induced Recrudescence of Premorbid Tic Disorder in Remission

October 14, 2005

, ,
PCC
Letter to the Editor

Dr. Leo Replies

December 1, 2003

JCP
Letter to the Editor

A Word of Caution About the Implied Role for Duloxetine in Pain Management

October 15, 2003

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe